Fig. 1From: Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case reportClinical course of the patient. DAA Direct-acting antiviral, HCV Hepatitis C virus, RFA Radiofrequency ablation, SVR 24 Sustained virologic response at 24 weeks, TACE Transcatheter arterial chemoembolizationBack to article page